Lupin logo

LUPIN - Lupin News Story

₹1089.8 25.2  2.4%

Last Trade - 20/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £4.72bn
Enterprise Value £4.92bn
Revenue £1.45bn
Position in Universe 81st / 3108

BRIEF-Lupin's Novel Labs Unit in New Jersey Gets 13 Observations in FDA Inspection

Mon 9th November, 2020 6:10am
Nov 9 (Reuters) - Lupin Ltd  LUPN.NS :
    * UNIT NOVEL LABORATORIES IN SOMERSET, NJ HAS CONCLUDED A
U.S. FDA
INSPECTION
    * INSPECTION AT SOMERSET, NJ FACILITY CLOSED WITH THIRTEEN
OBSERVATIONS
    * WILL WORK CLOSELY WITH AGENCY TO ADDRESS THEIR CONCERNS
    * FACILITY CONTRIBUTES LESS THAN 5% OF CO'S GLOBAL REVENUE
    * INSPECTION AT FACILITY WILL NOT HAVE IMPACT ON DISRUPTION
OF
SUPPLIES OR EXISTING REVENUE FROM OPERATIONS

Source text for Eikon:  ID:nBSE7GFn62 
Further company coverage:  LUPN.NS 

 ((bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.